Skip to main content
OpenTrials

Clinical trial condition

Phosphorus Metabolism Disorders

Explore clinical trials studying Phosphorus Metabolism Disorders. Study availability and eligibility vary by location and protocol.

186 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Phosphorus Metabolism Disorders trial results

Completed

X-linked Hypophosphatemia and FGF21

NCT03596554

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Centre de Référence des Maladies Rénales Rares - Centre de Référence des Maladies Rares du Calcium et du Phosphate - Service de Néphrologie, Rhumatologie et Dermatologie Pédiatriques - Hôpital Femme Mère Enfant Bron, France
  • Centre de Référence des Maladies Rares du Calcium et du Phosphore, Service d'Endocrinologie Pédiatrique - Hôpital du Kremlin Bicêtre Paris, France
  • Endocrinologie, Maladies Osseuses, Gynécologie, Génétique, Hôpital des Enfants, CHU de Toulouse Toulouse, France
View Trial Details
Completed

Dose Finding Study to Treat High Phosphate Levels in the Blood.

NCT02081534

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +14 more
Locations
  • Research Site Downey, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Whittier, California, United States
View all 41 locations
View Trial Details
Completed

An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)

NCT02675998

Conditions
Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Ardelyx Investigative Site 429 Huntsville, Alabama, United States
  • Ardelyx Investigative Site 425 Riverside, California, United States
  • Ardelyx Clinical Site 403 Denver, Colorado, United States
  • Ardelyx Investigative Site 410 Lauderdale Lakes, Florida, United States
View all 32 locations
View Trial Details
Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

NCT03237065

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +10 more
Locations
  • Pharmacosmos Investigational Site Muscle Shoals, Alabama, United States
  • Pharmacosmos Investigational Site Doral, Florida, United States
  • Pharmacosmos Investigational Site Miami, Florida, United States
  • Pharmacosmos Investigational Site Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

NCT03238911

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +10 more
Locations
  • Pharmacosmos Investigational Site Los Angeles, California, United States
  • Pharmacosmos Investigational Site Sacramento, California, United States
  • Pharmacosmos Investigational Site Santa Ana, California, United States
  • Pharmacosmos Investigational Site Clearwater, Florida, United States
View all 16 locations
View Trial Details

Related conditions